Dalton Bioanalytics
Digitizing the biochemical composition of blood for the future of human health
- Headquarters
- Los Angeles
- Employees
- 11–50
- Founded
- 2019
- Business Model
- B2B
- Website
- daltonbioanalytics.com
- Total Funding
- $250K
- Last Round
- $250K SeedAug 2019
About
Dalton Bioanalytics is at the forefront of the multiomics revolution, providing advanced CRO services for proteomics, metabolomics, lipidomics, and exposomics. Their proprietary Omni-MS® platform enables the analysis of over 1,000 biochemicals in a single sample, digitizing the complete biochemical composition of biofluid samples to accelerate drug discovery and biomarker research.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account